Propranolol, post-traumatic stress disorder and narrative identity

Area of Science:

• Neuroscience
• Psychiatry
• Bioethics

Background:

• Post-traumatic stress disorder (PTSD) presents challenges for patients unresponsive to conventional treatments.
• The use of propranolol for PTSD is debated, particularly concerning its effects on memory and narrative identity.
• Ethical considerations surrounding memory alteration and patient autonomy are central to the discussion.

Purpose of the Study:

• To evaluate the potential benefits and ethical justification of using propranolol for severe PTSD.
• To explore how propranolol's effects on memory align with the concept of narrative identity.
• To consider patient and physician roles in deciding on propranolol treatment.

Main Methods:

• The study is primarily a philosophical and ethical analysis, not a clinical trial.
• It examines existing research on propranolol's pharmacological effects on memory.
• It utilizes a narrative identity framework to assess the impact of memory alteration.

Main Results:

• Propranolol's alteration of memory quality is not considered a significant threat to narrative identity.
• For severe PTSD cases unresponsive to other treatments, propranolol may help restore self-narrative and life engagement.
• For less severe cases, potential risks may outweigh the benefits of propranolol.

Conclusions:

• Propranolol can be ethically justified for severe PTSD patients who have not responded to other therapies.
• The decision for propranolol use should be a collaborative one between patients, families, and physicians.
• This approach respects patient autonomy while considering the therapeutic potential of propranolol.